Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 72, n° 2
pages 364-365 (février 2015)
Doi : 10.1016/j.jaad.2014.09.055
Notes & Comments

Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment
 

Stephan Alexander Braun, MD a, , Peter Hevezi, PhD b, Bernhard Homey, MD a, Peter Arne Gerber, MD, DALM a
a Department of Dermatology, Medical Faculty, University of Düsseldorf, Germany 
b Department of Physiology and Biophysics, University of California, Irvine, California 

Correspondence to: Stephan Alexander Braun, MD, and Peter Arne Gerber, MD, DALM, Dept of Dermatology, Medical Faculty University of Düsseldorf, Moorenstr 5, 40225 Düsseldorf, Germany

 Funding sources: None.
 Disclosure: S. A. Braun and P. A. Gerber have received research funding from LEO Pharma. B. Homey is a consultant for Leo Pharma. P. A. Gerber has received lecture fees from Asclepion Laser Technologies. P. Hevezi has no conflicts of interest.


Top of the page

© 2014  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@